AMEX · TOVX

Theriva Biologics, Inc.

Healthcare · Biotechnology

$0.24

Up+$0.00 (+2.02%)

Updated Sep 12, 2026, 12:59 AM

SID Score

5.5/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap: 7.76M
P/E ratio: -0.05
Dividend yield: 0.00%
52-week range: $0.16 – $0.86
Volume: 357.98K
Avg. volume: 15.36M

Price performance

TOVX price history

1M range · 19 trading sessions · Daily adjusted prices

Last close: $0.24
Period change: +6.45%
Period low: $0.23
Period high: $0.25

Daily close

View OHLC price history

TOVX OHLC price history, latest 40 sessions
Date	Open	High	Low	Close	Volume
Sep 10, 2026	$0.2446	$0.2493	$0.2426	$0.2427	357.98K
Sep 9, 2026	$0.2514	$0.2514	$0.2411	$0.249	415.95K
Sep 8, 2026	$0.2455	$0.2533	$0.2455	$0.2471	377.58K
Sep 4, 2026	$0.26	$0.26	$0.2483	$0.253	431.52K
Sep 3, 2026	$0.2513	$0.2608	$0.243	$0.253	889.26K
Sep 2, 2026	$0.248	$0.2569	$0.245	$0.2481	419.3K
Sep 1, 2026	$0.2571	$0.2578	$0.2402	$0.249	516.31K
Aug 31, 2026	$0.2427	$0.2587	$0.2427	$0.25	300.13K
Aug 28, 2026	$0.2522	$0.2607	$0.2431	$0.2451	564.41K
Aug 27, 2026	$0.2432	$0.2621	$0.235	$0.2525	1.54M
Aug 26, 2026	$0.2386	$0.245	$0.236	$0.2432	438.4K
Aug 25, 2026	$0.2452	$0.2452	$0.2375	$0.2375	378.53K
Aug 24, 2026	$0.2364	$0.242	$0.233	$0.2351	365.72K
Aug 21, 2026	$0.237	$0.245	$0.2313	$0.235	521.67K
Aug 20, 2026	$0.232	$0.2377	$0.2268	$0.2302	413.28K
Aug 19, 2026	$0.2244	$0.2362	$0.2244	$0.2254	807.53K
Aug 18, 2026	$0.2347	$0.2347	$0.224	$0.2255	463.29K
Aug 17, 2026	$0.236	$0.2402	$0.2232	$0.2376	556.53K
Aug 14, 2026	$0.235	$0.2379	$0.22	$0.228	560.03K

Latest TOVX news

The latest Smart Investors Daily articles mentioning TOVX.

sec filingAug 12, 2026

Theriva Biologics, Inc. (TOVX) Reports Material Event to SEC

sec filingAug 12, 2026

Theriva Biologics, Inc. (TOVX) Files Quarterly Report for Q0

earningsAug 11, 2026

Theriva Biologics (TOVX) Misses Q2 Earnings Expectations

Latest TOVX news

The latest Smart Investors Daily articles mentioning TOVX.

Stock researchResearch & News · SEC Filings

Company

Overview Forecast Earnings Dividend Financials

Market Activity

Options Insider Trades Short Interest Institutional Ownership Sentiment

Research & News

Analysis Competitors News SEC Filings SID Coverage

TOVX research

SEC Filings

Recent regulatory filings and source documents.

TOVX SEC filings
Filed	Form	Description	Accepted	Document
Aug 11, 2026	10-Q	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	—	Open source
Aug 11, 2026	8-K	Form 8-K - Current report - Item 2.02 Item 9.01	—	Open source
Aug 6, 2026	8-K	Form 8-K - Current report - Item 7.01 Item 8.01 Item 9.01	—	Open source
Aug 4, 2026	8-K	Form 8-K - Current report - Item 5.02 Item 5.07 Item 9.01	—	Open source
Jul 7, 2026	8-K	Form 8-K - Current report - Item 7.01 Item 8.01 Item 9.01	—	Open source
Jun 29, 2026	DEF 14A	Form DEF 14A - Other definitive proxy statements	—	Open source
May 5, 2026	10-Q	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	—	Open source
May 5, 2026	8-K	Form 8-K - Current report - Item 2.02 Item 9.01	—	Open source
Apr 30, 2026	DEF 14A	Form DEF 14A - Other definitive proxy statements	—	Open source
Apr 17, 2026	8-K	Form 8-K - Current report - Item 7.01 Item 8.01 Item 9.01	—	Open source
Apr 9, 2026	8-K	Form 8-K - Current report - Item 8.01	—	Open source
Mar 23, 2026	8-K	Form 8-K - Current report - Item 7.01 Item 8.01 Item 9.01	—	Open source
Mar 16, 2026	DEF 14A	Form DEF 14A - Other definitive proxy statements	—	Open source
Mar 12, 2026	10-K	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	—	Open source
Mar 12, 2026	8-K	Form 8-K - Current report - Item 2.02 Item 9.01	—	Open source
Jan 12, 2026	8-K	Form 8-K - Current report - Item 8.01 Item 9.01	—	Open source
Jan 6, 2026	DEF 14A	Form DEF 14A - Other definitive proxy statements	—	Open source
Nov 12, 2025	10-Q	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	—	Open source
Nov 12, 2025	8-K	Form 8-K - Current report - Item 2.02 Item 9.01	—	Open source
Nov 10, 2025	DEF 14A	Form DEF 14A - Other definitive proxy statements	—	Open source
Nov 7, 2025	S-3	Form S-3 - Registration statement under Securities Act of 1933	—	Open source
Oct 31, 2025	PRE 14A	Form PRE 14A - Other preliminary proxy statements	—	Open source
Oct 29, 2025	8-K	Form 8-K - Current report - Item 8.01 Item 9.01	—	Open source
Oct 24, 2025	8-K	Form 8-K - Current report - Item 8.01 Item 9.01	—	Open source
Oct 20, 2025	8-K	Form 8-K - Current report - Item 8.01 Item 9.01	—	Open source
Oct 17, 2025	8-K	Form 8-K - Current report - Item 1.01 Item 3.02 Item 8.01 Item 9.01	—	Open source
Oct 14, 2025	8-K	Form 8-K - Current report - Item 7.01 Item 8.01 Item 9.01	—	Open source
Oct 8, 2025	8-K	Form 8-K - Current report - Item 8.01 Item 9.01	—	Open source
Oct 6, 2025	S-8	Form S-8 - Securities to be offered to employees in employee benefit plans	—	Open source
Oct 6, 2025	8-K	Form 8-K - Current report - Item 7.01 Item 8.01 Item 9.01	—	Open source
Oct 2, 2025	8-K	Form 8-K - Current report - Item 2.05	—	Open source
Sep 4, 2025	8-K	Form 8-K - Current report - Item 5.02 Item 5.07 Item 9.01	—	Open source
Aug 11, 2025	10-Q	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	—	Open source
Aug 11, 2025	8-K	Form 8-K - Current report - Item 2.02 Item 9.01	—	Open source
Jul 9, 2025	DEF 14A	Form DEF 14A - Other definitive proxy statements	—	Open source
Jun 25, 2025	8-K	Form 8-K - Current report - Item 8.01	—	Open source
Jun 20, 2025	8-K	Form 8-K - Current report - Item 8.01 Item 9.01	—	Open source
Jun 2, 2025	8-K	Form 8-K - Current report - Item 7.01 Item 8.01 Item 9.01	—	Open source
May 14, 2025	10-Q	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	—	Open source
May 14, 2025	8-K	Form 8-K - Current report - Item 2.02 Item 9.01	—	Open source
May 8, 2025	8-K	Form 8-K - Current report - Item 1.01 Item 8.01 Item 9.01	—	Open source
May 7, 2025	8-K	Form 8-K - Current report - Item 7.01 Item 8.01 Item 9.01	—	Open source
May 1, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
May 1, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
May 1, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
May 1, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Mar 31, 2025	8-K	Form 8-K - Current report - Item 7.01 Item 8.01 Item 9.01	—	Open source
Mar 21, 2025	S-1/A	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	—	Open source
Mar 6, 2025	10-K	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	—	Open source
Mar 6, 2025	8-K	Form 8-K - Current report - Item 2.02 Item 9.01	—	Open source

Filed

Form

Description

Accepted

Document

Aug 11, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

—

Open source

Aug 11, 2026

8-K

Form 8-K - Current report - Item 2.02 Item 9.01

—

Open source

Aug 6, 2026

8-K

Form 8-K - Current report - Item 7.01 Item 8.01 Item 9.01

—

Open source

Aug 4, 2026

8-K

Form 8-K - Current report - Item 5.02 Item 5.07 Item 9.01

—

Open source

Jul 7, 2026

8-K

Form 8-K - Current report - Item 7.01 Item 8.01 Item 9.01

—

Open source

Jun 29, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

—

Open source

May 5, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

—

Open source

May 5, 2026

8-K

Form 8-K - Current report - Item 2.02 Item 9.01

—

Open source

Apr 30, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

—

Open source

Apr 17, 2026

8-K

Form 8-K - Current report - Item 7.01 Item 8.01 Item 9.01

—

Open source

Apr 9, 2026

8-K

Form 8-K - Current report - Item 8.01

—

Open source

Mar 23, 2026

8-K

Form 8-K - Current report - Item 7.01 Item 8.01 Item 9.01

—

Open source

Mar 16, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

—

Open source

Mar 12, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

—

Open source

Mar 12, 2026

8-K

Form 8-K - Current report - Item 2.02 Item 9.01

—

Open source

Jan 12, 2026

8-K

Form 8-K - Current report - Item 8.01 Item 9.01

—

Open source

Jan 6, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

—

Open source

Nov 12, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

—

Open source

Nov 12, 2025

8-K

Form 8-K - Current report - Item 2.02 Item 9.01

—

Open source

Nov 10, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

—

Open source

Nov 7, 2025

S-3

Form S-3 - Registration statement under Securities Act of 1933

—

Open source

Oct 31, 2025

PRE 14A

Form PRE 14A - Other preliminary proxy statements

—

Open source

Oct 29, 2025

8-K

Form 8-K - Current report - Item 8.01 Item 9.01

—

Open source

Oct 24, 2025

8-K

Form 8-K - Current report - Item 8.01 Item 9.01

—

Open source

Oct 20, 2025

8-K

Form 8-K - Current report - Item 8.01 Item 9.01

—

Open source

Oct 17, 2025

8-K

Form 8-K - Current report - Item 1.01 Item 3.02 Item 8.01 Item 9.01

—

Open source

Oct 14, 2025

8-K

Form 8-K - Current report - Item 7.01 Item 8.01 Item 9.01

—

Open source

Oct 8, 2025

8-K

Form 8-K - Current report - Item 8.01 Item 9.01

—

Open source

Oct 6, 2025

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

—

Open source

Oct 6, 2025

8-K

Form 8-K - Current report - Item 7.01 Item 8.01 Item 9.01

—

Open source

Oct 2, 2025

8-K

Form 8-K - Current report - Item 2.05

—

Open source

Sep 4, 2025

8-K

Form 8-K - Current report - Item 5.02 Item 5.07 Item 9.01

—

Open source

Aug 11, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

—

Open source

Aug 11, 2025

8-K

Form 8-K - Current report - Item 2.02 Item 9.01

—

Open source

Jul 9, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

—

Open source

Jun 25, 2025

8-K

Form 8-K - Current report - Item 8.01

—

Open source

Jun 20, 2025

8-K

Form 8-K - Current report - Item 8.01 Item 9.01

—

Open source

Jun 2, 2025

8-K

Form 8-K - Current report - Item 7.01 Item 8.01 Item 9.01

—

Open source

May 14, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

—

Open source

May 14, 2025

8-K

Form 8-K - Current report - Item 2.02 Item 9.01

—

Open source

May 8, 2025

8-K

Form 8-K - Current report - Item 1.01 Item 8.01 Item 9.01

—

Open source

May 7, 2025

8-K

Form 8-K - Current report - Item 7.01 Item 8.01 Item 9.01

—

Open source

May 1, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

May 1, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

May 1, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

May 1, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Mar 31, 2025

8-K

Form 8-K - Current report - Item 7.01 Item 8.01 Item 9.01

—

Open source

Mar 21, 2025

S-1/A

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

—

Open source

Mar 6, 2025

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

—

Open source

Mar 6, 2025

8-K

Form 8-K - Current report - Item 2.02 Item 9.01

—

Open source

Theriva Biologics, Inc. (TOVX) Reports Material Event to SEC

Theriva Biologics, Inc. (TOVX) Files Quarterly Report for Q0

Theriva Biologics (TOVX) Misses Q2 Earnings Expectations

Featured By

Theriva Biologics, Inc. (TOVX) Reports Material Event to SEC

Theriva Biologics, Inc. (TOVX) Files Quarterly Report for Q0

Theriva Biologics (TOVX) Misses Q2 Earnings Expectations